Foley Hoag LLP represented Ginkgo Bioworks on the agreement. Ginkgo Bioworks (NYSE: DNA) announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug...
Ginkgo Bioworks’ Collaboration Agreement with Pfizer
Ginkgo Bioworks’ Acquisition of StrideBio’s Gene Therapy Assets
Foley Hoag represented Ginkgo Bioworks on the deal. Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading platform for cell programming and biosecurity, announced its acquisition of StrideBio’s adeno-associated...
Ginkgo Bioworks and Bayer’s Collaboration to Build Agricultural Biologicals R&D Platform
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, announced the closing a transaction with Bayer for a...
Ginkgo Bioworks’ Collaboration Agreement with Merck
Foley Hoag LLP represented Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
Ginkgo Bioworks’ $83 Million Collaboration With Bayer
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, signed an agreement with Bayer to expand Ginkgo’s platform capabilities...
Ginkgo Bioworks’ Acquisition of Zymergen Inc.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
Ginkgo Bioworks’ Collaboration with Novo Nordisk
Foley Hoag LLP represented Ginkgo Bioworks, Inc. on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
Ginkgo Bioworks’ Partnership with Microba Life Sciences
MinterEllison advised Ginkgo Bioworks in relation to its entry into a technical development agreement with Microba Life Sciences. Microba Life Sciences (ASX: MAP), a precision microbiome...
Microba Life Sciences’ A$30 Million Initial Public Offering
Thomson Geer advised Microba Life Sciences on the matter. MinterEllison supported Ginkgo on its participation as a cornerstone investor. Gut health business Microba Life Sciences Ltd...
Ginkgo Bioworks’ Acquisition of Dutch DNA Biotech
NautaDutilh assisted Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (“Ginkgo”), the organism company, announced it has signed a purchase agreement to acquire Dutch DNA Biotech...
Ginkgo Bioworks’ Acquisition of Dutch DNA Biotech
NautaDutilh assisted Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (“Ginkgo”), the organism company, announced it has signed a purchase agreement to acquire Dutch DNA Biotech...
Ginkgo Bioworks’ Collaboration and License Agreement with Biogen
Foley Hoag LLP advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc., the organism company, closed a collaboration and license agreement with Biogen (Nasdaq: BIIB) to...